- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02797353
Strengthening Maternal Neonatal and Child Health Services in a Rural District of Pakistan (SRC)
June 19, 2020 updated by: Dr Sajid Bashir Soofi, Aga Khan University
The Maternal Neonatal and Child health indicators in District Dadu of Pakistan portrays a dismal pictures and after the floods of 2010-2011 the health infrastructure of this district was badly affected.
Aga Khan University Pakistan is intending to implement a service delivery project for the improvement of Maternal Neonatal and Child health situation through evidence based MNCH interventions.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The Aga Khan University is implementing together with its local partners a MNCH project in five Union Councils (UC) in Dadu District in Sindh Province.
The project will scale up the already existing health services for MNCH in the district referral hospital and the five Basic Health Units (BHUs), one in each UC.
Institutional based services as well as their scope for outreach to pregnant women, mothers and children in the communities with the aim to promote safe deliveries as per WHO guidelines and Government policy will be enhanced.
In order to deliver quality services, the facilities will be renovated and equipped and the capacity of the existing staff will be strengthened through different training courses in MNCH.
In addition professionally trained Lady Health Visitors will be introduced in the BHUs, who will conduct all maternal services including deliveries in the BHU and the communities.
The health staff is furthermore responsible to establish and facilitate community support groups and raise communal awareness for the importance of mother and child health care as well as safe deliveries with skilled attendants.
Operational research is an integral part of this pilot project.
The research validates the progress and improvement of maternal and child health indicators.
The results will be used to lobby the scale up of MNCH interventions with the Ministry of Health in Pakistan.
Study Type
Interventional
Enrollment (Actual)
15000
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
1 day to 49 years (ADULT, CHILD)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Be a resident of target areas and consent to participate in the study
Exclusion Criteria:
- Do not fulfill the residence and consent criteria
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: HEALTH_SERVICES_RESEARCH
- Allocation: NON_RANDOMIZED
- Interventional Model: PARALLEL
- Masking: NONE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
EXPERIMENTAL: Intervention Arm
Antenatal Care, Post natal care, Skilled birth attendance, recognition and referrals of complicated cases, immunization
|
Antenatal care, postnatal care, skilled birth attendance, recognition and referral of complicated cases, immunization
|
NO_INTERVENTION: Control
This arm will receive the standard MNCH services as outlined in the MNCH policy of Government of Pakistan
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Maternal, Neonatal and infant mortality
Time Frame: 24 months
|
A 20% reduction in mortality rates is expected
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Antenatal Care
Time Frame: 12 months
|
A 40% Increase in Antenatal care is expected
|
12 months
|
Skilled Birth attendance
Time Frame: 12 months
|
A 40% increase in Skilled Birth attendance is expected
|
12 months
|
Essential Neonatal Care
Time Frame: 24 months
|
A 40% increase in uptake of Essential Neonatal Care
|
24 months
|
Child hood Immunization Rates
Time Frame: 24 months
|
A 30% increase in child hood immunization rates
|
24 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
January 1, 2013
Primary Completion (ACTUAL)
June 1, 2016
Study Completion (ACTUAL)
August 1, 2016
Study Registration Dates
First Submitted
June 8, 2016
First Submitted That Met QC Criteria
June 8, 2016
First Posted (ESTIMATE)
June 13, 2016
Study Record Updates
Last Update Posted (ACTUAL)
June 22, 2020
Last Update Submitted That Met QC Criteria
June 19, 2020
Last Verified
June 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Pathologic Processes
- Infections
- Systemic Inflammatory Response Syndrome
- Inflammation
- Wounds and Injuries
- Signs and Symptoms, Digestive
- Infant, Newborn, Diseases
- Sepsis
- Pregnancy Complications
- Obstetric Labor Complications
- Puerperal Disorders
- Death
- Hypertension, Pregnancy-Induced
- Uterine Hemorrhage
- Hemorrhage
- Diarrhea
- Eclampsia
- Postpartum Hemorrhage
- Asphyxia
- Asphyxia Neonatorum
- Neonatal Sepsis
Other Study ID Numbers
- 2787-Ped-ERC-13
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pneumonia
-
King Edward Memorial HospitalCompletedNosocomial Pneumonia | Healthcare-Associated Pneumonia | Aspiration Pneumonia | Ventilator-Associated PneumoniaIndia
-
Melinta Therapeutics, Inc.WithdrawnHospital-Acquired Bacterial Pneumonia | Ventilator-Associated Bacterial Pneumonia | Hospital-Acquired Pneumonia | Ventilator-Associated Pneumonia
-
Venatorx Pharmaceuticals, Inc.Department of Health and Human ServicesNot yet recruitingHospital-acquired Pneumonia | Ventilator-associated Pneumonia
-
Hannover Medical SchoolCharite University, Berlin, Germany; University of LeipzigUnknownCOVID-19 | Bacterial Pneumonia | Viral Pneumonia | Pneumonia Due to Streptococcus Pneumoniae | Pneumonia Due to H. Influenzae | Pneumonia, Organism Unspecified | Pneumonia in Diseases Classified Elsewhere | Pneumonia Due to Other Specified Infectious OrganismsGermany
-
Nantes University HospitalSociété Française d'Anesthésie et de RéanimationCompletedPneumonia | Sepsis | Ventilator-Associated Pneumonia | Hospital Acquired PneumoniaFrance
-
University Medical Centre LjubljanaUniversity of Ljubljana, Faculty of MedicineUnknownCommunity Acquired Pneumonia | Ventilator Associated Pneumonia | Hospital Acquired PneumoniaSlovenia
-
PfizerCompletedVentilator-associated Pneumonia (VAP) | Nosocomial Pneumonia (NP)Bulgaria, France, Italy, Korea, Republic of, Mexico, Peru, Poland, Russian Federation, Spain, Turkey, United Kingdom, Vietnam, Philippines, China, Ukraine, Argentina, Brazil, Hungary, Romania, India, Japan, Taiwan, Latvia, Czechia, Slov... and more
-
Arpida AGTerminatedHospital-Acquired Pneumonia | Ventilator-Associated Pneumonia | Health-Care-Associated Pneumonia
-
ShionogiCompletedHospital Acquired Pneumonia (HAP) | Healthcare-associated Pneumonia (HCAP) | Ventilator Associated Pneumonia (VAP)Israel, Spain, United States, Belgium, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Japan, Latvia, Philippines, Puerto Rico, Russian Federation, Serbia, Taiwan, Ukraine
-
Methodist Health SystemCompletedHospital-acquired Pneumonia | Ventilator-associated PneumoniaUnited States
Clinical Trials on Maternal Neonatal and Child Health Interventions
-
International Centre for Diarrhoeal Disease Research...Johns Hopkins Bloomberg School of Public Health; World Health Organization; U... and other collaboratorsCompletedChildhood IllnessBangladesh
-
Columbia UniversityBill and Melinda Gates Foundation; United NationsCompletedChild SurvivalEthiopia, Ghana, Kenya, Malawi, Mali, Nigeria, Rwanda, Senegal, Tanzania, Uganda
-
Hannah Brown AmoakohUniversity of Ghana; Ghana Health ServicesCompletedEclampsia | Asphyxia | Neonatal Jaundice | Postpartum Haemorrhage | Pre-eclampsia | Maternal Death | Neonatal Sepsis | Neonatal Death | Pregnancy Induced Hypertension | Puerperal SepsisGhana
-
University Hospital, MontpellierCompletedUterine Rupture | Mode of DeliveryFrance
-
Cairo UniversityCompletedUmbilical Cord ClampingEgypt
-
Inonu UniversityCompletedEducation | Mobile Messages | Breastfeeding Self-efficacy | Breastfeeding Attitude | Maternal Experience SatisfactionTurkey
-
University Hospital, MontpellierActive, not recruitingTwin Pregnancy With Antenatal Problem | Pregnant With ComplicationFrance
-
University of Maryland, BaltimoreJohns Hopkins University; Eunice Kennedy Shriver National Institute of Child...CompletedDepression | Obesity | OverweightUnited States
-
Aga Khan UniversityUnited Nations; Global Affairs CanadaRecruitingReproductive Behavior, Family Planning ServicesPakistan
-
University Hospital, MontpellierCompletedMode of Delivery | Premature Rupture of Membranes at TermFrance